All articles by Andrew Turley – Page 10
-
News
UK tilts towards appraisal of Avastin as eye drug
UK authorities press forward in long running debate over two drugs from the Genentech
-
News
DuPont signs Danisco deal for $5.8b
The deal takes the chemical giant strongly into the food ingredient and enzyme markets in Europe
-
News
Funding pharma whistleblowers
US whistleblower lawsuits filed against drug companies could provide attractive investment opportunities for hedge funds
-
News
A chemical regulation comes of age
For the European chemical industry, 2010 was all about registration under the Reach regulation, the focus of our roundup
-
News
Reach deadline passes, registrations fall short of predictions
Registrations for EU chemicals legislation 28 per cent lower than forecast, but regulators insist the process was a success
-
News
Industry 'disturbed' at Europe BPA ban
EU's decision to ban bisphenol A in baby bottles draws criticism
-
News
Stanford to challenge patent rights in Supreme Court
US Supreme Court will hear intellectual property case being fought between US university and pharma firm Roche
-
News
Company snapshot: Novo Nordisk
What's the secret of Danish diabetes specialist Novo Nordisk's success?
-
News
Hungarian toxic mud reaches Danube
Caustic red mud from a ruptured chemical reservoir in Hungary has reached the Danube
-
News
Sanofi hostile move for Genzyme
Sanofi-Aventis makes a hostile $18.5 billion takeover bid for US biotech, Genzyme
-
News
ECHA to go easy on 'exceptional cases'
Some firms will be allowed to miss the submission deadline for Europe-wide chemicals legislation
-
News
Bacteria factories for Taxol precursors
E. coli bacteria have been engineered to produce precursors of one of the most widely used cancer drugs
-
News
End of the road for Avandia?
Risk of cardiac side effects finally causes GlaxoSmithKline's troubled diabetes drug to be pulled from European markets and severely restricted in the US
-
News
Free trade could throttle generics from India
Upcoming trade agreements could stifle India's key role in supplying affordable Aids drugs to developing countries
-
News
Vince Cable: science cuts are coming
Only research that is academically outstanding or has commercial appeal should be funded says UK business minister in first speech on science
-
News
Man charged in Dow trade secrets case
A former Dow research scientist has been charged with stealing trade secrets
-
News
DNA must do its job for patent protection
A European court has ruled that patents for DNA do not give protection when the sequences are no longer performing the task they were inserted to do
-
News
What next for BP?
It has been over two months since the explosion on BP's Deepwater Horizon oil rig, but what's in store for the company at the eye of the storm?
-
News
Biocatalyst improves diabetes drug production
A new biocatalyst for chiral amine synthesis could 'significantly improve' industrial production of the one of the world's best selling diabetes therapies